Results 21 to 30 of about 388,843 (271)

Identification of Patients at High Cardiovascular Risk [PDF]

International Journal of Biomedicine, 2012
Objective: To identify individuals at high cardiovascular risk (CVR) to check for an additional estimate of CVR with the use of the ESH/ESC Guidelines (2003, 2007) in patients earlier classified as being at low and moderate risk on «SCORE».
Igor V. Sergienko, PhD, ScD, Saule J. Urazalina, PhD, Valery V. Kukharchuk, PhD, ScD, Yuri A. Karpov, PhD, ScD, Sergey A. Boytsov, PhD, ScD   +4 more
doaj  

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process

Rambam Maimonides Medical Journal, 2016
Thyroid cancer is an increasingly common malignancy, with a rapidly rising prevalence worldwide. The social and economic ramifications of the increase in thyroid cancer are multiple.
Gal Omry-Orbach
doaj   +1 more source

L1-regularized neural ranking for risk stratification and its application to prediction of time to distant metastasis in luminal node negative chemotherapy naïve breast cancer patients [PDF]

arXiv, 2021
Can we predict if an early stage cancer patient is at high risk of developing distant metastasis and what clinicopathological factors are associated with such a risk? In this paper, we propose a ranking based censoring-aware machine learning model for answering such questions.
arxiv  

Homogeneity Tests and Interval Estimations of Risk Differences for Stratified Bilateral and Unilateral Correlated Data [PDF]

, 2023
In clinical trials studying paired parts of a subject with binary outcomes, it is expected to collect measurements bilaterally. However, there are cases where subjects contribute measurements for only one part. By utilizing combined data, it is possible to gain additional information compared to using bilateral or unilateral data alone.
arxiv   +1 more source

Risk adjusted 30‐day mortality and serious adverse event rates among a large, multi‐center cohort of emergency department patients with acute heart failure

Journal of the American College of Emergency Physicians Open, 2022
Background Admission rates for emergency department (ED) patients with acute heart failure (AHF) remain elevated. Use of a risk stratification tool could improve disposition decision making by identifying low‐risk patients who may be safe for outpatient ...
Dana R. Sax, Dustin G. Mark, Jamal S. Rana, Sean P. Collins, Jie Huang, Mary E. Reed, CREST Network   +6 more
doaj   +1 more source

Role of Multidetector CT Imaging in the Risk Stratification of Gastrointestinal Stromal Tumors (GISTs)–A Retrospective Analysis

Journal of Gastrointestinal and Abdominal Radiology, 2021
Background Gastrointestinal stromal tumors (GISTs) are the most common gastrointestinal mesenchymal neoplasms which can arise from any part of the gastrointestinal tract (GIT) or an extraintestinal location.
Geena Benjamin, Thara Pratap, Mangalanandan Sreenivasan, Dhanya Jacob, Agnes Thomas, Bala Sankar, Amith Itty   +6 more
doaj   +1 more source

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

Molecular Oncology, EarlyView.
In the era of immunotherapies, many patients either do not respond or eventually develop resistance. We propose to pave the way for proteomic analysis of surface‐expressed proteins called surfaceome, of circulating tumor cells. This approach seeks to identify immune evasion mechanisms and discover potential therapeutic targets. Circulating tumor cells (
Doryan Masmoudi, Jérome Vialaret, Christophe Hirtz, Catherine Alix‐Panabières   +3 more
wiley   +1 more source

The Swedish version of the STarT MSK Tool: cross-cultural adaption, test–retest reliability, and aspects of validity

BMC Musculoskeletal Disorders, 2023
Background Musculoskeletal disorders (MSDs) are a common reason for seeking primary health care. The STarT Musculoskeletal (MSK) tool is designed to stratify patients suffering from MSDs to risk groups, based on prognostic factors.
Eva Rasmussen-Barr, Maria Sövelid, Rasmus Krantz, Jonathan C. Hill   +3 more
doaj   +1 more source

Updating Clinical Risk Stratification Models Using Rank-Based Compatibility: Approaches for Evaluating and Optimizing Clinician-Model Team Performance [PDF]

arXiv, 2023
As data shift or new data become available, updating clinical machine learning models may be necessary to maintain or improve performance over time. However, updating a model can introduce compatibility issues when the behavior of the updated model does not align with user expectations, resulting in poor user-model team performance.
arxiv  

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

Molecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, Simon P. Gampenrieder, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Michael Hubalek, Katja Schmitz, Zsuzsanna Bago‐Horvath, Andreas Petzer, Sonja Heibl, Ellen Heitzer, Marija Balic, Michael Gnant   +14 more
wiley   +1 more source